On October 27, 2015 Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) reported two poster presentations at the 2015 AACR (Free AACR Whitepaper)-NCI-EORTC AACR-NCI-EORTC (Free AACR-NCI-EORTC Whitepaper) International Conference on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR) (Free ASGCT Whitepaper) (Free EORTC-NCI-AACR Whitepaper) being held November 5-9 in Boston, Massachusetts (Press release, Sunesis, OCT 27, 2015, View Source;p=RssLanding&cat=news&id=2103102 [SID:1234507820]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details for the poster presentations are as follows:

Date and Time: Sunday, November 8, 2015 from 12:30 p.m. to 3:30 p.m. Eastern Time
Poster Title: PDK1 inhibitors SNS-229 and SNS-510 cause pathway modulation, apoptosis and tumor regression in hematologic cancer models in addition to solid tumors
Abstract/Poster Number: C198
Session Title: Therapeutic Agents: Small Molecule Kinase Inhibitors
Session ID: Poster Session C
Location: Exhibit Hall C-D

The full abstract can be viewed here.

Date and Time: Sunday, November 8, 2015 from 12:30 p.m. to 3:30 p.m. Eastern Time
Poster Title: SNS-062 is a potent noncovalent BTK inhibitor with comparable activity against wild type BTK and BTK with an acquired resistance mutation
Abstract/Poster Number: C186
Session Title: Therapeutic Agents: Small Molecule Kinase Inhibitors
Session ID: Poster Session C
Location: Exhibit Hall C-D